Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Menarini Silicon Biosystems launches new breakthrough DEPArray™ PLUS image-based cell sorter to isolate rare cells with single cell precision

Thursday, May 27, 2021

Menarini Silicon Biosystems a pioneer of liquid biopsy and single cell technologies announced today the launch of the new highly automated DEPArray PLUS now available with fluorescent channels This robust imagebased cellsorting technology combines m...

BioInvent and Transgene receive IND approval from the U.S. FDA for BT-001, a novel oncolytic virus for the treatment of solid tumors

Thursday, May 27, 2021

BioInvent International AB a biotech company focused on the discovery and development of novel and firstinclass immunemodulatory antibodies for cancer immunotherapy and Transgene Euronext Paris TNG a biotech company that designs and develops virusbas...

Ajinomoto Bio-Pharma Services Expands Fill Finish Capacity with New Multi-Purpose Fill Suite

Wednesday, May 26, 2021

Ajinomoto BioPharma Services a leading provider of biopharmaceutical contract development and manufacturing services today announced it will soon open a high speed multipurpose fill finish line in its stateoftheart commercial manufacturing facility l...

Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases

Wednesday, May 26, 2021

Alloy Therapeutics and Pyxis Oncology announced the formation of a joint venture named Kyma Therapeutics to develop immunemodulating antibodies for novel targets in cancer and autoimmune diseases Kyma Therapeutics will advance programs directed to im...

Dorian and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery

Tuesday, May 25, 2021

Shanghai Stock Exchange listed company HitGen Inc HitGen today announced that it has entered into a research collaboration agreement with Dorian Therapeutics Inc Dorian a private biotechnology company developing senoblockers a new class of therapeuti...

Boehringer Ingelheim's Investigational Treatment for Cognitive Impairment Associated with Schizophrenia Receives FDA Breakthrough Therapy Designation

Tuesday, May 25, 2021

Boehringer Ingelheim today announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation BTD for BI for the treatment of Cognitive Impairment Associated with Schizophrenia CIAS The company also announced the pla...

Libtayo® (cemiplimab) Receives Positive CHMP Opinion for the Treatment in Europe of Two Advanced Cancers

Monday, May 24, 2021

Regeneron Pharmaceuticals Inc and Sanofi today announced that the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP has adopted positive opinions for Libtayo cemiplimab as monotherapy in two advanced cancers The CHMP...

Liminal BioSciences Announces Closing of Divestiture of Plasma Collection Centers and Enters into Option Agreement with Kedrion

Saturday, May 22, 2021

Liminal BioSciences Inc a clinicalstage biopharmaceutical company announced today that it has closed on the previously announced divestment of its plasma collection centers Prometic Plasma Resources Inc and Prometic Plasma Resources USA Inc collecti...

AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan

Friday, May 21, 2021

AstraZenecas COVID vaccine Vaxzevria ChAdOxS Recombinant formerly AZD has been granted a special approval for emergency use in Japan for active immunisation of individuals aged years and older to prevent COVID caused by SARSCoV The Japanese Ministry...

Takeda Announces Approval of Moderna’s COVID-19 Vaccine in Japan

Friday, May 21, 2021

Takeda Pharmaceutical Company Limited announced that the Ministry of Health Labour and Welfare MHLW granted special approval under article of the Pharmaceuticals and Medical Devices Act for emergency use of Modernas mRNA COVID vaccine TAK now known...